Home » Topics » Regulatory

Regulatory
RSS

Lidocaine nasal drops shown effective for fast migraine pain relief

Aug. 9, 1996

No Comments

Actiq to undergo phase III clinical trials

Aug. 9, 1996

No Comments

Raloxifene claimed as treatment for excess bradykinin-related conditions

July 26, 1996

No Comments

Phase III results indicate Ergoset's effectiveness and safety

July 26, 1996

No Comments

Leiras claims oral delivery system for oxybutynin chloride

July 26, 1996

No Comments

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

July 26, 1996

No Comments

Pharmacia & Upjohn introduces new dosage strength for Fragmin

July 26, 1996

No Comments

SR-140333 claimed as a cardioregulatory drug

July 26, 1996

No Comments

BES and BENSPM claimed as vascular proliferative disorders treatment

July 26, 1996

No Comments

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

July 26, 1996

No Comments

BioWorld Premium

Enjoy extended coverage for the most complete market view with BioWorld, BioWorld MedTech, and BioWorld Asia in a single, easy to access subscription.

Regulatory
RSS

Lidocaine nasal drops shown effective for fast migraine pain relief

Actiq to undergo phase III clinical trials

Raloxifene claimed as treatment for excess bradykinin-related conditions

Phase III results indicate Ergoset's effectiveness and safety

Leiras claims oral delivery system for oxybutynin chloride

Novo Nordisk claims xanomeline as potential urinary bladder disorder treatment

Pharmacia & Upjohn introduces new dosage strength for Fragmin

SR-140333 claimed as a cardioregulatory drug

BES and BENSPM claimed as vascular proliferative disorders treatment

Glaxo Wellcome claims GR-79236 for reducing myocardial injury

Today's news in brief

Today's news in brief

J&J’s Ottava robotic system approved for US pivotal trial

‘Evo’ AI can design complete genomes

Apollo signs near-$1B deal for Sunshine’s FGF21/GLP-1 injection

Regulatory RSS

Regulatory
RSS